_id
6919f2453c536f8df2318632
Ticker
BNN.XETRA
Name
BRAIN Biotech AG
Exchange
XETRA
Address
Darmstädter Strasse 34-36, Zwingenberg, Germany, 64673
Country
Germany
Sector
Basic Materials
Industry
Specialty Chemicals
Currency
EUR
Website
https://www.brain-biotech.com
Description
BRAIN Biotech AG provides bio-based products and solutions in Germany, the United States, France, the Netherlands, and the United Kingdom. It operates through three segments: BioProducts, BioScience, and BioIncubator. The company offers enzymes, biocatalysts, microorganisms, and other bioactive natural compounds to produce foodstuffs and animal feed, cosmetics, and medical products, as well as for industrial applications in chemical companies, waste and hazardous materials disposal, and energy and raw materials production. The company was formerly known as B.R.A.I.N. Biotechnology Research and Information Network AG and changed its name to BRAIN Biotech AG in April 2021. The company was founded in 1993 and is headquartered in Zwingenberg, Germany.
Last Close
2.47
Volume
8239
Current Price
2.7
Change
2.0242914979757014
Last Updated
2025-12-30T11:56:36.964Z
Image
https://logo.clearbit.com/www.brain-biotech.com
Ipo Date
-
Market Cap
51560088
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
-
Sentiment Sources
0
Rating
3.75
Strong Buy
0
Buy
3
Hold
1
Sell
0
Strong Sell
0
Current Quarter
2025-06-30
Revenue
13463000
Cost Of Revenue
5354000
Gross Profit
8109000
Operating Expenses
8865000
Operating Income
-756000
Interest Expense
1458000
Pretax Income
-701000
Net Income
-608000
Eps
-0.02782927745263244
Dividends Per Share
-
Shares Outstanding
21847495
Income Tax Expense
-92000
EBITDA
1989000
Operating Margin
-5.615390329049989
Total Other Income Expense Net
55000
Cash
10531000
Short Term Investments
-
Receivables
-
Inventories
-
Total Current Assets
30166000
Property Plant Equipment
-
Total Assets
72441000
Payables
-
Short Term Debt
-
Long Term Debt
-
Total Liabilities
66267000
Equity
6174000
Bs_currency_symbol
EUR
Depreciation
1232000
Change In Working Capital
1883000
Cash From Operations
-1839000
Capital Expenditures
496000
Cash From Investing
-49000
Cash From Financing
-2389000
Net Change In Cash
-4341000
Cf_currency_symbol
EUR
PE
-
PB
9.554298104956269
ROE
-9.847748623258827
ROA
-0.8393037092254387
FCF
-2335000
Fcf Percent
-0.1734383124117953
Piotroski FScore
0
Health Score
8
Deep Value Investing Score
2
Defensive Investing Score
3
Dividend Investing Score
1
Economic Moat Investing Score
3.3
Garp Investing Score
2
Growth Investing Score
2
Momentum Investing Score
3
Net Net Investing Score
2.5
Quality Investing Score
1
Value Investing Score
1.5
Quarters > 0 > quarter
2025-06-30
Quarters > 0 > income Statement > revenue
13463000
Quarters > 0 > income Statement > cost Of Revenue
5354000
Quarters > 0 > income Statement > gross Profit
8109000
Quarters > 0 > income Statement > operating Expenses
8865000
Quarters > 0 > income Statement > operating Income
-756000
Quarters > 0 > income Statement > interest Expense
1458000
Quarters > 0 > income Statement > pretax Income
-701000
Quarters > 0 > income Statement > net Income
-608000
Quarters > 0 > income Statement > eps
-0.02782927745263244
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
21847495
Quarters > 0 > income Statement > income Tax Expense
-92000
Quarters > 0 > income Statement > EBITDA
1989000
Quarters > 0 > income Statement > operating Margin
-5.615390329049989
Quarters > 0 > income Statement > total Other Income Expense Net
55000
Quarters > 0 > income Statement > currency_symbol
EUR
Quarters > 0 > balance Sheet > cash
10531000
Quarters > 0 > balance Sheet > short Term Investments
-
Quarters > 0 > balance Sheet > receivables
-
Quarters > 0 > balance Sheet > inventories
-
Quarters > 0 > balance Sheet > total Current Assets
30166000
Quarters > 0 > balance Sheet > property Plant Equipment
-
Quarters > 0 > balance Sheet > total Assets
72441000
Quarters > 0 > balance Sheet > payables
-
Quarters > 0 > balance Sheet > short Term Debt
-
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
66267000
Quarters > 0 > balance Sheet > equity
6174000
Quarters > 0 > balance Sheet > currency_symbol
EUR
Quarters > 0 > cash Flow > net Income
-608000
Quarters > 0 > cash Flow > depreciation
1232000
Quarters > 0 > cash Flow > change In Working Capital
1883000
Quarters > 0 > cash Flow > cash From Operations
-1839000
Quarters > 0 > cash Flow > capital Expenditures
496000
Quarters > 0 > cash Flow > cash From Investing
-49000
Quarters > 0 > cash Flow > cash From Financing
-2389000
Quarters > 0 > cash Flow > net Change In Cash
-4341000
Quarters > 0 > cash Flow > currency_symbol
EUR
Quarters > 0 > ratios > PE
-0.02782927745263244
Quarters > 0 > ratios > PB
9.554298104956269
Quarters > 0 > ratios > ROE
-9.847748623258827
Quarters > 0 > ratios > ROA
-0.8393037092254387
Quarters > 0 > ratios > FCF
-2335000
Quarters > 0 > ratios > Piotroski FScore
0
Quarters > 0 > ratios > fcf Percent
-0.1734383124117953
Quarters > 0 > health Score
8
Quarters > 1 > quarter
2025-03-31
Quarters > 1 > income Statement > revenue
12124000
Quarters > 1 > income Statement > cost Of Revenue
5202000
Quarters > 1 > income Statement > gross Profit
6922000
Quarters > 1 > income Statement > operating Expenses
8746000
Quarters > 1 > income Statement > operating Income
-1824000
Quarters > 1 > income Statement > interest Expense
1374000
Quarters > 1 > income Statement > pretax Income
-3264000
Quarters > 1 > income Statement > net Income
-3059000
Quarters > 1 > income Statement > eps
-0.14001605218355698
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
21847495
Quarters > 1 > income Statement > income Tax Expense
-116000
Quarters > 1 > income Statement > EBITDA
-653000
Quarters > 1 > income Statement > operating Margin
-15.044539755856153
Quarters > 1 > income Statement > total Other Income Expense Net
-1440000
Quarters > 1 > income Statement > currency_symbol
EUR
Quarters > 1 > balance Sheet > cash
14872000
Quarters > 1 > balance Sheet > short Term Investments
241000
Quarters > 1 > balance Sheet > receivables
7808000
Quarters > 1 > balance Sheet > inventories
10279000
Quarters > 1 > balance Sheet > total Current Assets
34908000
Quarters > 1 > balance Sheet > property Plant Equipment
29170000
Quarters > 1 > balance Sheet > total Assets
79086000
Quarters > 1 > balance Sheet > payables
5814000
Quarters > 1 > balance Sheet > short Term Debt
163000
Quarters > 1 > balance Sheet > long Term Debt
4427000
Quarters > 1 > balance Sheet > total Liabilities
71895000
Quarters > 1 > balance Sheet > equity
6012000
Quarters > 1 > balance Sheet > currency_symbol
EUR
Quarters > 1 > cash Flow > net Income
-3059000
Quarters > 1 > cash Flow > depreciation
1237000
Quarters > 1 > cash Flow > change In Working Capital
-1883000
Quarters > 1 > cash Flow > cash From Operations
-1618000
Quarters > 1 > cash Flow > capital Expenditures
496000
Quarters > 1 > cash Flow > cash From Investing
-261000
Quarters > 1 > cash Flow > cash From Financing
-1038000
Quarters > 1 > cash Flow > net Change In Cash
-2949000
Quarters > 1 > cash Flow > currency_symbol
EUR
Quarters > 1 > ratios > PE
-0.14001605218355698
Quarters > 1 > ratios > PB
9.811749251497007
Quarters > 1 > ratios > ROE
-50.881570192947436
Quarters > 1 > ratios > ROA
-3.867941228536024
Quarters > 1 > ratios > FCF
-2114000
Quarters > 1 > ratios > Piotroski FScore
1
Quarters > 1 > ratios > fcf Percent
-0.17436489607390301
Quarters > 1 > health Score
9
Quarters > 2 > quarter
2024-12-31
Quarters > 2 > income Statement > revenue
13108000
Quarters > 2 > income Statement > cost Of Revenue
5883000
Quarters > 2 > income Statement > gross Profit
7225000
Quarters > 2 > income Statement > operating Expenses
9901000
Quarters > 2 > income Statement > operating Income
-2676000
Quarters > 2 > income Statement > interest Expense
1330000
Quarters > 2 > income Statement > pretax Income
-4099000
Quarters > 2 > income Statement > net Income
-4034000
Quarters > 2 > income Statement > eps
-0.184643594151183
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
21847495
Quarters > 2 > income Statement > income Tax Expense
-63000
Quarters > 2 > income Statement > EBITDA
-1557000
Quarters > 2 > income Statement > operating Margin
-20.41501373207202
Quarters > 2 > income Statement > total Other Income Expense Net
-1423000
Quarters > 2 > income Statement > currency_symbol
EUR
Quarters > 2 > balance Sheet > cash
17821000
Quarters > 2 > balance Sheet > short Term Investments
-
Quarters > 2 > balance Sheet > receivables
-
Quarters > 2 > balance Sheet > inventories
-
Quarters > 2 > balance Sheet > total Current Assets
37105000
Quarters > 2 > balance Sheet > property Plant Equipment
-
Quarters > 2 > balance Sheet > total Assets
80325000
Quarters > 2 > balance Sheet > payables
-
Quarters > 2 > balance Sheet > short Term Debt
19798000
Quarters > 2 > balance Sheet > long Term Debt
31013000
Quarters > 2 > balance Sheet > total Liabilities
70019000
Quarters > 2 > balance Sheet > equity
10306000
Quarters > 2 > balance Sheet > currency_symbol
EUR
Quarters > 2 > cash Flow > net Income
-4034000
Quarters > 2 > cash Flow > depreciation
1212000
Quarters > 2 > cash Flow > change In Working Capital
-3333000
Quarters > 2 > cash Flow > cash From Operations
-3333000
Quarters > 2 > cash Flow > capital Expenditures
0
Quarters > 2 > cash Flow > cash From Investing
-257000
Quarters > 2 > cash Flow > cash From Financing
-5852000
Quarters > 2 > cash Flow > net Change In Cash
-9350000
Quarters > 2 > cash Flow > currency_symbol
EUR
Quarters > 2 > ratios > PE
-0.184643594151183
Quarters > 2 > ratios > PB
5.723679070444402
Quarters > 2 > ratios > ROE
-39.14224723462061
Quarters > 2 > ratios > ROA
-5.022097727980081
Quarters > 2 > ratios > FCF
-3333000
Quarters > 2 > ratios > Piotroski FScore
1
Quarters > 2 > ratios > fcf Percent
-0.2542722001830943
Quarters > 2 > health Score
12
Quarters > 3 > quarter
2024-09-30
Quarters > 3 > income Statement > revenue
14237000
Quarters > 3 > income Statement > cost Of Revenue
6553000
Quarters > 3 > income Statement > gross Profit
7684000
Quarters > 3 > income Statement > operating Expenses
11134000
Quarters > 3 > income Statement > operating Income
-3450000
Quarters > 3 > income Statement > interest Expense
471000
Quarters > 3 > income Statement > pretax Income
-3617000
Quarters > 3 > income Statement > net Income
-3994000
Quarters > 3 > income Statement > eps
-0.18281272063456244
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
21847495
Quarters > 3 > income Statement > income Tax Expense
316000
Quarters > 3 > income Statement > EBITDA
-1838000
Quarters > 3 > income Statement > operating Margin
-24.232633279483036
Quarters > 3 > income Statement > total Other Income Expense Net
-167000
Quarters > 3 > income Statement > currency_symbol
EUR
Quarters > 3 > balance Sheet > cash
27171000
Quarters > 3 > balance Sheet > short Term Investments
58000
Quarters > 3 > balance Sheet > receivables
7921000
Quarters > 3 > balance Sheet > inventories
9420000
Quarters > 3 > balance Sheet > total Current Assets
45658000
Quarters > 3 > balance Sheet > property Plant Equipment
27855000
Quarters > 3 > balance Sheet > total Assets
88737000
Quarters > 3 > balance Sheet > payables
5611000
Quarters > 3 > balance Sheet > short Term Debt
8651000
Quarters > 3 > balance Sheet > long Term Debt
4151000
Quarters > 3 > balance Sheet > total Liabilities
74851000
Quarters > 3 > balance Sheet > equity
12617000
Quarters > 3 > balance Sheet > currency_symbol
EUR
Quarters > 3 > cash Flow > net Income
-3994000
Quarters > 3 > cash Flow > depreciation
4823000
Quarters > 3 > cash Flow > change In Working Capital
3322000
Quarters > 3 > cash Flow > cash From Operations
-913000
Quarters > 3 > cash Flow > capital Expenditures
1552000
Quarters > 3 > cash Flow > cash From Investing
-351000
Quarters > 3 > cash Flow > cash From Financing
15417000
Quarters > 3 > cash Flow > net Change In Cash
14205000
Quarters > 3 > cash Flow > currency_symbol
EUR
Quarters > 3 > ratios > PE
-0.18281272063456244
Quarters > 3 > ratios > PB
4.675298129507807
Quarters > 3 > ratios > ROE
-31.655702623444558
Quarters > 3 > ratios > ROA
-4.500940982904538
Quarters > 3 > ratios > FCF
-2465000
Quarters > 3 > ratios > Piotroski FScore
1
Quarters > 3 > ratios > fcf Percent
-0.1731404087939875
Quarters > 3 > health Score
12
Annuals > 0 > quarter
2024-09-30
Annuals > 0 > income Statement > revenue
54631000
Annuals > 0 > income Statement > cost Of Revenue
54230000
Annuals > 0 > income Statement > gross Profit
401000
Annuals > 0 > income Statement > operating Expenses
39414000
Annuals > 0 > income Statement > operating Income
-8852000
Annuals > 0 > income Statement > interest Expense
1939000
Annuals > 0 > income Statement > pretax Income
-10990000
Annuals > 0 > income Statement > net Income
-11127000
Annuals > 0 > income Statement > eps
-0.509303240485923
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
21847495
Annuals > 0 > income Statement > income Tax Expense
111000
Annuals > 0 > income Statement > EBITDA
-4228000
Annuals > 0 > income Statement > operating Margin
-16.203254562427926
Annuals > 0 > income Statement > total Other Income Expense Net
-2138000
Annuals > 0 > income Statement > currency_symbol
EUR
Annuals > 0 > balance Sheet > cash
27171000
Annuals > 0 > balance Sheet > short Term Investments
58000
Annuals > 0 > balance Sheet > receivables
7921000
Annuals > 0 > balance Sheet > inventories
9368000
Annuals > 0 > balance Sheet > total Current Assets
45658000
Annuals > 0 > balance Sheet > property Plant Equipment
27855000
Annuals > 0 > balance Sheet > total Assets
88737000
Annuals > 0 > balance Sheet > payables
5611000
Annuals > 0 > balance Sheet > short Term Debt
8651000
Annuals > 0 > balance Sheet > long Term Debt
4151000
Annuals > 0 > balance Sheet > total Liabilities
74851000
Annuals > 0 > balance Sheet > equity
12617000
Annuals > 0 > balance Sheet > currency_symbol
EUR
Annuals > 0 > cash Flow > net Income
-11127000
Annuals > 0 > cash Flow > depreciation
4823000
Annuals > 0 > cash Flow > change In Working Capital
1837000
Annuals > 0 > cash Flow > cash From Operations
-3583000
Annuals > 0 > cash Flow > capital Expenditures
1729000
Annuals > 0 > cash Flow > cash From Investing
-1689000
Annuals > 0 > cash Flow > cash From Financing
26991000
Annuals > 0 > cash Flow > net Change In Cash
21819000
Annuals > 0 > cash Flow > currency_symbol
EUR
Annuals > 0 > ratios > PE
-0.509303240485923
Annuals > 0 > ratios > PB
4.328979749544265
Annuals > 0 > ratios > ROE
-88.19053657763335
Annuals > 0 > ratios > ROA
-12.539301531491937
Annuals > 0 > ratios > FCF
-5312000
Annuals > 0 > ratios > Piotroski FScore
1
Annuals > 0 > ratios > fcf Percent
-0.09723417107503066
Annuals > 0 > health Score
12
Annuals > 1 > quarter
2023-09-30
Annuals > 1 > income Statement > revenue
55335000
Annuals > 1 > income Statement > cost Of Revenue
51867000
Annuals > 1 > income Statement > gross Profit
3468000
Annuals > 1 > income Statement > operating Expenses
10183000
Annuals > 1 > income Statement > operating Income
-6715000
Annuals > 1 > income Statement > interest Expense
942000
Annuals > 1 > income Statement > pretax Income
-7489000
Annuals > 1 > income Statement > net Income
-8279000
Annuals > 1 > income Statement > eps
-0.37894504610253943
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
21847495
Annuals > 1 > income Statement > income Tax Expense
625000
Annuals > 1 > income Statement > EBITDA
-1977000
Annuals > 1 > income Statement > operating Margin
-12.135176651305683
Annuals > 1 > income Statement > total Other Income Expense Net
-774000
Annuals > 1 > income Statement > currency_symbol
EUR
Annuals > 1 > balance Sheet > cash
5352000
Annuals > 1 > balance Sheet > short Term Investments
55000
Annuals > 1 > balance Sheet > receivables
9565000
Annuals > 1 > balance Sheet > inventories
9756000
Annuals > 1 > balance Sheet > total Current Assets
25476000
Annuals > 1 > balance Sheet > property Plant Equipment
28720000
Annuals > 1 > balance Sheet > total Assets
70937000
Annuals > 1 > balance Sheet > payables
5617000
Annuals > 1 > balance Sheet > short Term Debt
4659000
Annuals > 1 > balance Sheet > long Term Debt
11058000
Annuals > 1 > balance Sheet > total Liabilities
47923000
Annuals > 1 > balance Sheet > equity
21771000
Annuals > 1 > balance Sheet > currency_symbol
EUR
Annuals > 1 > cash Flow > net Income
-8279000
Annuals > 1 > cash Flow > depreciation
4654000
Annuals > 1 > cash Flow > change In Working Capital
139000
Annuals > 1 > cash Flow > cash From Operations
-4218000
Annuals > 1 > cash Flow > capital Expenditures
2638000
Annuals > 1 > cash Flow > cash From Investing
562000
Annuals > 1 > cash Flow > cash From Financing
459000
Annuals > 1 > cash Flow > net Change In Cash
-3091000
Annuals > 1 > cash Flow > currency_symbol
EUR
Annuals > 1 > ratios > PE
-0.37894504610253943
Annuals > 1 > ratios > PB
2.5087840475862384
Annuals > 1 > ratios > ROE
-38.02765146295531
Annuals > 1 > ratios > ROA
-11.670919266391305
Annuals > 1 > ratios > FCF
-6856000
Annuals > 1 > ratios > Piotroski FScore
0
Annuals > 1 > ratios > fcf Percent
-0.12389988253365862
Annuals > 1 > health Score
20
Annuals > 2 > quarter
2022-09-30
Annuals > 2 > income Statement > revenue
49509000
Annuals > 2 > income Statement > cost Of Revenue
48083000
Annuals > 2 > income Statement > gross Profit
1426000
Annuals > 2 > income Statement > operating Expenses
8951000
Annuals > 2 > income Statement > operating Income
-7525000
Annuals > 2 > income Statement > interest Expense
572000
Annuals > 2 > income Statement > pretax Income
-6165000
Annuals > 2 > income Statement > net Income
-6590000
Annuals > 2 > income Statement > eps
-0.3016364118632365
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
21847495
Annuals > 2 > income Statement > income Tax Expense
176000
Annuals > 2 > income Statement > EBITDA
-1296000
Annuals > 2 > income Statement > operating Margin
-15.199256700801875
Annuals > 2 > income Statement > total Other Income Expense Net
1360000
Annuals > 2 > income Statement > currency_symbol
EUR
Annuals > 2 > balance Sheet > cash
8443000
Annuals > 2 > balance Sheet > short Term Investments
362000
Annuals > 2 > balance Sheet > receivables
11381000
Annuals > 2 > balance Sheet > inventories
9624000
Annuals > 2 > balance Sheet > total Current Assets
30384000
Annuals > 2 > balance Sheet > property Plant Equipment
28738000
Annuals > 2 > balance Sheet > total Assets
77992000
Annuals > 2 > balance Sheet > payables
6754000
Annuals > 2 > balance Sheet > short Term Debt
3037000
Annuals > 2 > balance Sheet > long Term Debt
2619000
Annuals > 2 > balance Sheet > total Liabilities
43744000
Annuals > 2 > balance Sheet > equity
29638000
Annuals > 2 > balance Sheet > currency_symbol
EUR
Annuals > 2 > cash Flow > net Income
-6341000
Annuals > 2 > cash Flow > depreciation
4340000
Annuals > 2 > cash Flow > change In Working Capital
3635000
Annuals > 2 > cash Flow > cash From Operations
-1485000
Annuals > 2 > cash Flow > capital Expenditures
6082000
Annuals > 2 > cash Flow > cash From Investing
-12686000
Annuals > 2 > cash Flow > cash From Financing
-1966000
Annuals > 2 > cash Flow > net Change In Cash
-16102000
Annuals > 2 > cash Flow > currency_symbol
EUR
Annuals > 2 > ratios > PE
-0.3016364118632365
Annuals > 2 > ratios > PB
1.8428617821715365
Annuals > 2 > ratios > ROE
-22.234968621364466
Annuals > 2 > ratios > ROA
-8.449584572776695
Annuals > 2 > ratios > FCF
-7567000
Annuals > 2 > ratios > Piotroski FScore
0
Annuals > 2 > ratios > fcf Percent
-0.15284089761457512
Annuals > 2 > health Score
24
Annuals > 3 > quarter
2021-09-30
Annuals > 3 > income Statement > revenue
38389000
Annuals > 3 > income Statement > cost Of Revenue
40343000
Annuals > 3 > income Statement > gross Profit
-1954000
Annuals > 3 > income Statement > operating Expenses
6431000
Annuals > 3 > income Statement > operating Income
-6548000
Annuals > 3 > income Statement > interest Expense
553000
Annuals > 3 > income Statement > pretax Income
-4276000
Annuals > 3 > income Statement > net Income
-4972000
Annuals > 3 > income Statement > eps
-0.24931076004581462
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
19942982
Annuals > 3 > income Statement > income Tax Expense
403000
Annuals > 3 > income Statement > EBITDA
2014000
Annuals > 3 > income Statement > operating Margin
-17.056969444372086
Annuals > 3 > income Statement > total Other Income Expense Net
2272000
Annuals > 3 > income Statement > currency_symbol
EUR
Annuals > 3 > balance Sheet > cash
24545000
Annuals > 3 > balance Sheet > short Term Investments
105000
Annuals > 3 > balance Sheet > receivables
6957000
Annuals > 3 > balance Sheet > inventories
7011000
Annuals > 3 > balance Sheet > total Current Assets
39114000
Annuals > 3 > balance Sheet > property Plant Equipment
24291000
Annuals > 3 > balance Sheet > total Assets
77737000
Annuals > 3 > balance Sheet > payables
3831000
Annuals > 3 > balance Sheet > short Term Debt
2643000
Annuals > 3 > balance Sheet > long Term Debt
3481000
Annuals > 3 > balance Sheet > total Liabilities
35910000
Annuals > 3 > balance Sheet > equity
38783000
Annuals > 3 > balance Sheet > currency_symbol
EUR
Annuals > 3 > cash Flow > net Income
-4680000
Annuals > 3 > cash Flow > depreciation
4014000
Annuals > 3 > cash Flow > change In Working Capital
1345000
Annuals > 3 > cash Flow > cash From Operations
-3906000
Annuals > 3 > cash Flow > capital Expenditures
1262000
Annuals > 3 > cash Flow > cash From Investing
-2180000
Annuals > 3 > cash Flow > cash From Financing
11572000
Annuals > 3 > cash Flow > net Change In Cash
5602000
Annuals > 3 > cash Flow > currency_symbol
EUR
Annuals > 3 > ratios > PE
-0.24931076004581462
Annuals > 3 > ratios > PB
1.2855492097052832
Annuals > 3 > ratios > ROE
-12.820050021916817
Annuals > 3 > ratios > ROA
-6.395924720532051
Annuals > 3 > ratios > FCF
-5168000
Annuals > 3 > ratios > Piotroski FScore
0
Annuals > 3 > ratios > fcf Percent
-0.13462189689754878
Annuals > 3 > health Score
30
Valuation > metrics > PE
-0.02782927745263244
Valuation > metrics > PB
9.554298104956269
Valuation > final Score
20
Valuation > verdict
218.5% Overvalued
Profitability > metrics > ROE
-9.847748623258827
Profitability > metrics > ROA
-2.01551415500895
Profitability > metrics > Net Margin
-0.04516081111193642
Profitability > final Score
0
Profitability > verdict
Weak
Risk > metrics > Debt Equity
10.7332361516035
Risk > metrics > Interest Coverage
-0.5185185185185185
Risk > final Score
4
Risk > verdict
High
Liquidity > final Score
50
Liquidity > verdict
Weak
Prev Valuations > 0
20
Prev Valuations > 1
22.763209295555978
Prev Valuations > 2
33.24701870492193
Prev Profitabilities > 0
0
Prev Profitabilities > 1
0
Prev Profitabilities > 2
0
Prev Risks > 0
1
Prev Risks > 1
-2
Prev Risks > 2
-23
Prev Liquidities > 0
100
Prev Liquidities > 1
97
Prev Liquidities > 2
100
Updated At
2026-01-20T23:05:45.128Z
Earnings History > 0 > period
2026-03-31
Earnings History > 0 > report Date
2026-05-26
Earnings History > 0 > date
2026-03-31
Earnings History > 0 > before After Market
BeforeMarket
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
-
Earnings History > 0 > eps Estimate
-
Earnings History > 0 > eps Difference
0
Earnings History > 0 > surprise Percent
-
Earnings History > 1 > period
2025-12-31
Earnings History > 1 > report Date
2026-02-24
Earnings History > 1 > date
2025-12-31
Earnings History > 1 > before After Market
BeforeMarket
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
-
Earnings History > 1 > eps Estimate
-
Earnings History > 1 > eps Difference
0
Earnings History > 1 > surprise Percent
-
Earnings History > 2 > period
2019-03-31
Earnings History > 2 > report Date
2019-05-29
Earnings History > 2 > date
2019-03-31
Earnings History > 2 > before After Market
-
Earnings History > 2 > currency
EUR
Earnings History > 2 > eps Actual
-0.1559
Earnings History > 2 > eps Estimate
-
Earnings History > 2 > eps Difference
0
Earnings History > 2 > surprise Percent
-
Earnings History > 3 > period
2018-06-30
Earnings History > 3 > report Date
2018-08-31
Earnings History > 3 > date
2018-06-30
Earnings History > 3 > before After Market
AfterMarket
Earnings History > 3 > currency
-
Earnings History > 3 > eps Actual
-0.12
Earnings History > 3 > eps Estimate
0.1
Earnings History > 3 > eps Difference
-0.22
Earnings History > 3 > surprise Percent
-220
Earnings History > 4 > period
2018-03-31
Earnings History > 4 > report Date
2018-05-30
Earnings History > 4 > date
2018-03-31
Earnings History > 4 > before After Market
BeforeMarket
Earnings History > 4 > currency
-
Earnings History > 4 > eps Actual
-0.13
Earnings History > 4 > eps Estimate
-0.04
Earnings History > 4 > eps Difference
-0.09
Earnings History > 4 > surprise Percent
-225
Earnings History > 5 > period
2017-12-31
Earnings History > 5 > report Date
2018-02-28
Earnings History > 5 > date
2017-12-31
Earnings History > 5 > before After Market
BeforeMarket
Earnings History > 5 > currency
-
Earnings History > 5 > eps Actual
-0.1
Earnings History > 5 > eps Estimate
-
Earnings History > 5 > eps Difference
0
Earnings History > 5 > surprise Percent
-
Earnings History > 6 > period
2017-09-30
Earnings History > 6 > report Date
2017-11-29
Earnings History > 6 > date
2017-09-30
Earnings History > 6 > before After Market
-
Earnings History > 6 > currency
EUR
Earnings History > 6 > eps Actual
-0.12
Earnings History > 6 > eps Estimate
-
Earnings History > 6 > eps Difference
0
Earnings History > 6 > surprise Percent
-
Earnings History > 7 > period
2017-06-30
Earnings History > 7 > report Date
2017-08-30
Earnings History > 7 > date
2017-06-30
Earnings History > 7 > before After Market
-
Earnings History > 7 > currency
EUR
Earnings History > 7 > eps Actual
-0.1009
Earnings History > 7 > eps Estimate
-
Earnings History > 7 > eps Difference
0
Earnings History > 7 > surprise Percent
-
Earnings History > 8 > period
2017-03-31
Earnings History > 8 > report Date
2017-05-31
Earnings History > 8 > date
2017-03-31
Earnings History > 8 > before After Market
-
Earnings History > 8 > currency
EUR
Earnings History > 8 > eps Actual
-0.0797
Earnings History > 8 > eps Estimate
-
Earnings History > 8 > eps Difference
0
Earnings History > 8 > surprise Percent
-
Earnings History > 9 > period
2016-12-31
Earnings History > 9 > report Date
2017-01-16
Earnings History > 9 > date
2016-12-31
Earnings History > 9 > before After Market
AfterMarket
Earnings History > 9 > currency
EUR
Earnings History > 9 > eps Actual
-0.39
Earnings History > 9 > eps Estimate
-0.1
Earnings History > 9 > eps Difference
-0.29
Earnings History > 9 > surprise Percent
-290
Earnings History > 10 > period
2016-09-30
Earnings History > 10 > report Date
2016-11-30
Earnings History > 10 > date
2016-09-30
Earnings History > 10 > before After Market
-
Earnings History > 10 > currency
EUR
Earnings History > 10 > eps Actual
-0.15
Earnings History > 10 > eps Estimate
-0.1
Earnings History > 10 > eps Difference
-0.05
Earnings History > 10 > surprise Percent
-50
Earnings History > 11 > period
2016-06-30
Earnings History > 11 > report Date
2016-08-31
Earnings History > 11 > date
2016-06-30
Earnings History > 11 > before After Market
-
Earnings History > 11 > currency
EUR
Earnings History > 11 > eps Actual
-0.1517
Earnings History > 11 > eps Estimate
-
Earnings History > 11 > eps Difference
0
Earnings History > 11 > surprise Percent
-
Earnings History > 12 > period
2016-03-31
Earnings History > 12 > report Date
2016-03-31
Earnings History > 12 > date
2016-03-31
Earnings History > 12 > before After Market
-
Earnings History > 12 > currency
EUR
Earnings History > 12 > eps Actual
-0.2488
Earnings History > 12 > eps Estimate
-
Earnings History > 12 > eps Difference
0
Earnings History > 12 > surprise Percent
-
BRAIN Biotech AG provides bio-based products and solutions in Germany, the United States, France, the Netherlands, and the United Kingdom. It operates through three segments: BioProducts, BioScience, and BioIncubator. The company offers enzymes, biocatalysts, microorganisms, and other bioactive natural compounds to produce foodstuffs and animal feed, cosmetics, and medical products, as well as for industrial applications in chemical companies, waste and hazardous materials disposal, and energy and raw materials production. The company was formerly known as B.R.A.I.N. Biotechnology Research and Information Network AG and changed its name to BRAIN Biotech AG in April 2021. The company was founded in 1993 and is headquartered in Zwingenberg, Germany.
Stock Price
€0.00
increase compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/A(Last Updated 2025-06-30)
Rating:
BUY
$
Analyst Picks
Strong Buy
0
Buy
3
Hold
1
Sell
0
Strong Sell
0
(Last Updated 2025-06-30)
Health Score
Price to Book Ratio (P/B)
-
Very High
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Free Cash Flow - Revenue % (FCF)
-
Very Low
Low ≤ 5%
High ≥ 15%
Debt to Equity
-
Very Low
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 0.00% of the total shares of BRAIN Biotech AG
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
2025-12-31
EPS Estimate
—
Date
2019-03-31
EPS Actual
-0.1559
EPS Estimate
—
EPS Difference
0
Surprise Percent
0%
(Last Updated 2025-06-30)
(Last Updated 2025-06-30)
Revenue
€ 0
Cost Of Revenue
€ 0
Gross Profit
€ 0
Operating Expenses
€ 0
Operating Income
€ 0
Interest Expense
€ 0
Pretax Income
€ 0
Net Income
€ 0
Income Tax Expense
€ 0
EBITDA
€ 0
Total Other Income Expense Net
€ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-06-30)
Cash
€ 0
Short Term Investments
€ 0
Receivables
€ 0
Inventories
€ 0
Total Current Assets
€ 0
Property Plant Equipment
€ 0
Total Assets
€ 0
Payables
€ 0
Short Term Debt
€ 0
Long Term Debt
€ 0
Total Liabilities
€ 0
Equity
€ 0
(Last Updated 2025-06-30)
Net Income
€ 0
Depreciation
€ 0
Change In Working Capital
€ 0
Cash From Operations
€ 0
Capital Expenditures
€ 0
Cash From Investing
€ 0
Cash From Financing
€ 0
Net Change In Cash
€ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.